Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain*

The Ewing's sarcoma (EWS) oncogene contains an N-terminal transcriptional activation domain (EWSactivation domain, EAD) and a C-terminal RNA-binding domain (RBD). Although it has been established that the EAD is a potent trans-activation domain that is required for the oncogenic activity of several EWS fusion proteins (EFPs), the precise function of the RBD and the normal role of intact EWS are poorly characterized. Here we show that a cis-linked RBD can strongly and specifically repress trans-activation by the EAD. Fusion proteins containing the RBD are expressed at normal levels, are nuclear-localized, and can bind to DNA both in vitro and in vivo, demonstrating that the RBD represses trans-activation directly at the promoter. The RNA recognition motif within the RBD is not required for repression, whereas regions of the RBD containing multiple RGG motifs play a critical role. The finding that the RBD can antagonize transcriptional activation by EWS provides the first direct evidence of a role for the RBD in transcription. Further studies of the repression phenomenon should illuminate key molecular interactions that distinguish EWS from EFPs and provide insights into the normal cellular function of EWS.

[1]  M. Green,et al.  The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. , 1991, Genes & development.

[2]  L. Tora,et al.  The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties , 1999, Oncogene.

[3]  C. Gunter,et al.  Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein* , 1998, The Journal of Biological Chemistry.

[4]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[5]  S. Pan,et al.  The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly , 1998, Oncogene.

[6]  L. Lee,et al.  The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. , 1996, Oncogene.

[7]  D. Immanuel,et al.  TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. , 1997, Journal of cell science.

[8]  Olivier Delattre,et al.  EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes , 1998, Molecular and Cellular Biology.

[9]  H. Zinszner,et al.  A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. , 1994, Genes & development.

[10]  K. A. Lee,et al.  In vitro phosphorylation studies of a conserved region of the transcription factor ATF1. , 1993, Nucleic acids research.

[11]  E. Reddy,et al.  EWS/Fli-1 chimeric protein is a transcriptional activator. , 1993, Cancer research.

[12]  V. Nikodem,et al.  hnRNP U Inhibits Carboxy-Terminal Domain Phosphorylation by TFIIH and Represses RNA Polymerase II Elongation , 1999, Molecular and Cellular Biology.

[13]  S. Barnache,et al.  The Transcription Factor Spi-1/PU.1 Interacts with the Potential Splicing Factor TLS* , 1998, The Journal of Biological Chemistry.

[14]  M. Montminy,et al.  Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Ouchida,et al.  The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. , 1994, Oncogene.

[16]  G. Walter,et al.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen , 1984, Journal of virology.

[17]  J. Pelletier,et al.  The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties , 1998, Oncogene.

[18]  K. A. Lee,et al.  Transcriptional regulation by CREB and its relatives. , 1993, Biochimica et biophysica acta.

[19]  D. Immanuel,et al.  A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited , 1997, Oncogene.

[20]  M. Montminy,et al.  Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressers , 1993, Nature.

[21]  N. Maizels,et al.  A Specific Isoform of hnRNP D Interacts with DNA in the LR1 Heterodimer: Canonical RNA Binding Motifs in a Sequence-specific Duplex DNA Binding Protein* , 1998, The Journal of Biological Chemistry.

[22]  T. Rabbitts,et al.  Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. A. Lee,et al.  The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43 , 1990, Molecular and cellular biology.

[24]  K. A. Lee,et al.  Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. , 1995, Oncogene.

[25]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[26]  Kevin A. W. Lee,et al.  MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription , 1998, Oncogene.

[27]  R. Lührmann,et al.  Molecular cloning and subcellular localisation of the snRNP-associated protein 69KD, a structural homologue of the proto-oncoproteins TLS and EWS with RNA and DNA-binding properties. , 1996, Journal of molecular biology.

[28]  Erica A Golemis,et al.  Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II , 1998, Oncogene.

[29]  Jun Ma,et al.  A new class of yeast transcriptional activators , 1987, Cell.

[30]  C. Denny,et al.  Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. , 1995, Oncogene.

[31]  F. Rauscher.  Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors. , 1997, Current topics in microbiology and immunology.

[32]  C. Denny,et al.  Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor. , 1997, Current topics in microbiology and immunology.

[33]  G. McKnight,et al.  Regulation of transcription by cyclic AMP-dependent protein kinase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Carey,et al.  A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. , 1992, The EMBO journal.

[35]  G. Childs,et al.  The Transcriptional Repressor ZFM1 Interacts with and Modulates the Ability of EWS to Activate Transcription* , 1998, The Journal of Biological Chemistry.

[36]  D. Brow,et al.  Control of pre-mRNA accumulation by the essential yeast protein Nrd1 requires high-affinity transcript binding and a domain implicated in RNA polymerase II association. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Ouchida,et al.  TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. , 1994, Oncogene.

[38]  M. Ouchida,et al.  Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias , 1997, Oncogene.

[39]  Hiroshi Handa,et al.  NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation , 1999, Cell.

[40]  D. Ron.  TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. , 1997, Current topics in microbiology and immunology.

[41]  P. Raychaudhuri,et al.  trans-Activation by the hnRNP K Protein Involves an Increase in RNA Synthesis from the Reporter Genes (*) , 1996, The Journal of Biological Chemistry.

[42]  K. Tanaka,et al.  EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. , 1997, The Journal of clinical investigation.

[43]  M. Malim,et al.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. , 1992, Genes & development.

[44]  G. Thomas,et al.  Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. , 1993, Genomics.

[45]  W. Schaffner,et al.  C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively. , 1993, Nucleic acids research.

[46]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Storm,et al.  The Prooncoprotein EWS Binds Calmodulin and Is Phosphorylated by Protein Kinase C through an IQ Domain* , 1997, The Journal of Biological Chemistry.

[48]  D. L. Weeks,et al.  Adenovirus E3-early promoter: sequences required for activation by E1A. , 1985, Nucleic acids research.

[49]  M. Schemper,et al.  EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[50]  William Arbuthnot Sir Lane,et al.  Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS , 1999, Current Biology.

[51]  M. Ouchida,et al.  Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. , 1995, Oncogene.

[52]  P. Chambon,et al.  hTAF(II)68, a novel RNA/ssDNA‐binding protein with homology to the pro‐oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. , 1996, The EMBO journal.

[53]  G. Thomas,et al.  EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts , 1993, Nature Genetics.

[54]  J. Pelletier,et al.  The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct , 1998, Oncogene.